MarkATarnopolskyMDPhD

Professor of Pediatrics and Medicine at McMaster University / President and CEO of Exerkine Corporation / Director of Neuromuscular and Neurometabolic Clinic at McMaster University Medical Center

Join to view full profile

Dr. Tarnopolsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tarnopolsky's full profile

Already have an account?

Office
McMaster University Medical Center
(Canada)
Rochester, NY 14642

Education & Training

Michael G. DeGroote School of MedicineClass of 1988

Clinical Trials

(Mol-SHARE) Molecular Study of Health Assessment and Risk in Ethnic Groups Start of enrollment: 2005 Nov 01
Unknown status
Older Adult Training Study With Creatine and CLA Start of enrollment: 2003 Aug 01
Completed
Not Applicable
A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia Start of enrollment: 2008 Apr 01
Completed
Phase 1, Phase 2
GNE-Myopathy Disease Monitoring Program (GNEM-DMP): A Registry and Prospective Observational Natural History Study to Assess GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM) Start of enrollment: 2013 Apr 05
Completed
Evaluation of a Supplement for Weight Management in Obese and Overweight Individuals Start of enrollment: 2019 Mar 01
Completed
Not Applicable
Myotonic Dystrophy Type 1 Aerobic Exercise Study Start of enrollment: 2019 Dec 06
Completed
Not Applicable
Supplementation for Male Subfertility Start of enrollment: 2024 Feb 02
Not yet recruiting
Phase 2
Roles: Principal Investigator, Contact
Home-based Training and Supplementation in DM1 Patients Start of enrollment: 2024 Jan 01
Not yet recruiting
Phase 3
Roles: Contact, Principal Investigator
Nutritional Therapy in Late-onset Pompe Disease Start of enrollment: 2024 Apr 01
Not yet recruiting
Phase 2
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

270 citations
Exome Sequencing Reveals De Novo WDR45 Mutations Causing a Phenotypically Distinct, X-Linked Dominant Form of NBIA
Tobias B. Haack, Penelope Hogarth, Michael C. Kruer, Allison Gregory, Thomas Wieland
American Journal of Human Genetics. 2012-12-07
180 citations
Massage Therapy Attenuates Inflammatory Signaling After Exercise-Induced Muscle Damage
Justin D. Crane, Daniel I. Ogborn, Colleen Cupido, Simon Melov, Alan Hubbard
Science Translational Medicine. 2012-02-01
252 citations
High responders to resistance exercise training demonstrate differential regulation of skeletal muscle microRNA expression
Peter K. Davidsen, Iain J. Gallagher, Joseph W. Hartman, Mark A. Tarnopolsky, Flemming Dela
Journal of Applied Physiology. 2011-02-01

Press Mentions

This Scientist Made a Skin-Care Brand That Mimics the Effects of Exercise on Your Skin—Here’s HowApril 16th, 2021
An Autosomal Dominant Neurological Disorder Caused by De Novo Variants in FAR1 Resulting in Uncontrolled Synthesis of Ether LipidsNovember 26th, 2020
Tips for Diagnosing Metabolic MyopathiesSeptember 17th, 2019
Join now to see all